Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership
Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation
Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors
Nuvation Bio Soars: Pioneering Trial Success Ignites "Buy" Rating from Jefferies
Zevra Therapeutics Shares Skyrocket Amid Intense Takeover Speculation
Market Meltdowns & Mega-Deals: Unpacking Today's Biggest Stock Movers
Agios Shares Plummet as FDA Halts Pyrukynd's Thalassemia Review, Sending Shockwaves Through Biotech